J. Paul Burnett

LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors

Anne Kingston, Paul L. Ornstein, Rebecca A. Wright et al. · Neuropharmacology · 1998 · 364 citations

Functional Selectivity, Medicine, Drug Discovery +7

Cytoplasmic Inclusion Bodies in <i>Escherichia coli</i> Producing Biosynthetic Human Insulin Proteins

Daniel C. Williams, Richard M. Van Frank, William L. Muth et al. · Science · 1982 · 312 citations

Engineering, Protein Assembly, Molecular Biology +20

LY354740 is a Potent and Highly Selective Group II Metabotropic Glutamate Receptor Agonist in Cells Expressing Human Glutamate Receptors

Darryle D. Schoepp, Bryan G. Johnson, Rebecca A. Wright et al. · Neuropharmacology · 1997 · 225 citations

Functional Selectivity, Medicine, Neurotransmitter +5

The Novel Metabotropic Glutamate Receptor Agonist 2 R ,4 R -APDC Potentiates Stimulation of Phosphoinositide Hydrolysis in the Rat Hippocampus by 3,5-dihydroxyphenylglycine: Evidence for a Synergistic Interaction Between Group 1 and Group 2 Receptors

Darryle D. Schoepp, Craig R. Salhoff, Rebecca A. Wright et al. · Neuropharmacology · 1996 · 105 citations

Rat Hippocampus, Phosphoinositide Hydrolysis, Group 2 +12

Pharmacological analysis of 4-carboxyphenylglycine derivatives: Comparison of effects on mGluR1α and mGluR5a subtypes

Ann E. Kingston, J. Paul Burnett, Nancy G. Mayne et al. · Neuropharmacology · 1995 · 89 citations

Molecular Pharmacology, Pharmacological Study, Biochemistry +9